Rapid Emulsion Technology by OILS to power State B Cannabis Beverages, a female-led brand focused on mood modulating productsState B’s first three infused beverage SKUs have been validated through Nextleaf Lab’s human trials programNextleaf Solutions Ltd. an extraction company that owns one of the largest portfolios of U.S. patents for the extraction and distillation of cannabinoids, with State B Cannabis Beverage …
Rapid Emulsion Technology by OILS(TM) to power State B Cannabis Beverages, a female-led brand focused on mood modulating products
State B’s first three infused beverage SKUs have been validated through Nextleaf Lab’s human trials program
Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf”, “OILS”, or the “Company”), an extraction company that owns one of the largest portfolios of U.S. patents for the extraction and distillation of cannabinoids, with State B Cannabis Beverage Co. (“State B”), is pleased to announce details on the Canadian launch of State B beverages developed with Nextleaf’s proprietary Rapid Emulsion Technology by OILS™ (“Rapid Tech”).
State B is a female-owned cannabis beverage company founded by Kelly Woods, a proven entrepreneur, certified sommelier, distiller, and herbalist. Woods challenged herself to create a beneficial alternative to alcohol that would not only ‘take the edge off’ but also include healing herbs that would compliment the benefits of cannabis.
Kelly Woods – State B Cannabis Beverage Co Founder and CEO
To view an enhanced version of this graphic, please visit:
The launch of State B beverages will be enacted through a manufacturing partnership with BevCanna Enterprises Inc. (CSE:BEV), and powered by Nextleaf’s proprietary Rapid Tech. State B’s Sparkle, Resolve, and Zing beverages are not seltzer’s, they are purposeful products that are said to be “first of its kind” designed as mood modulating, consciousness shifting beverages. All three SKUs for the initial launch were validated by the Company’s wholly-owned subsidiary Nextleaf Labs Ltd., through its human trials program.
State B’s Sparkle, Resolve, and Zing cannabis beverages
To view an enhanced version of this graphic, please visit:
State B’s differentiation and mandate to alter the liquid refreshment paradigm earned Woods and her team an opportunity to present on CBC’s Dragons’ Den. State B is the first cannabis product to be featured on Dragons’ Den and the episode is expected to air this fall in the show’s 16th season.
“It is an exciting time, and we couldn’t be happier to launch State B beverages with Nextleaf’s proprietary Rapid Emulsion Technology,” said State B Founder and Chief Executive Officer Kelly Woods. “The Dragons’ Den opportunity helped validate an initial theory of mine that there was an opportunity to provide a purposeful product to an underdeveloped area in cannabis beverages around female consumption. We all know that the ‘wine Mom’ is socially accepted so we designed these beverages for women like me, who have children and want a healthier alternative to alcohol, which was responsible for 3 million deaths last year,” said Woods.
“Nextleaf is delighted to work with a female-led business such as State B and we are thrilled to combine Kelly’s expertise developing beverages with our Rapid Emulsion Technology,” said Nextleaf CEO Paul Pedersen. “We are excited for the launch of State B branded products and the brand’s appearance on Dragons’ Den, which we think is a reflection of cannabis 2.0 becoming mainstream adult-use products.”
Nextleaf is an innovative cannabis processor that owns one of the largest portfolios of U.S. patents for the extraction, distillation, and delivery of cannabinoids. Nextleaf supplies cannabis oils to its wholesale customers and distributes consumer products under its award-winning prohibition-era brand, Glacial Gold™. Nextleaf’s proprietary closed-loop automated extraction plant in Metro Vancouver has a design capacity to process 600 kilos of dried cannabis into oil per day. Nextleaf is developing delivery technology through its Health Canada Research Licence with sensory evaluation of cannabis via human testing. The Company owns 15 U.S. patents and has been issued over 80 patents globally.
For more information please contact:
Jason McBride, Corporate Development
604-283-2301 (ext. 219)
On behalf of the Board of Directors of the Company,
Paul Pedersen, CEO
Certain statements contained in this press release constitute “forward-looking statements”. All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company’s ability to capitalize on its IP portfolio, the Company’s strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company’s MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The CSE has not reviewed or approved the contents of this press release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/89753
News Provided by Newsfile via QuoteMedia